Guidelines recommend considering severe obesity (BMI > 40 kg/m2), uncontrolled diabetes mellitus, untreated severe obstructive sleep apnea, active cancer and psychosis as contraindications to hGH therapy. This evidence concerns the gene GH1 and Obesity.